N- methyl- 3- (((4- pyridin- 4- ylbenzoyl)amino)methyl)benzamide

structure in first source

Also Known As:

PF 4950834; PF-4950834; PF4950834

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Barnes, Peter J: 1 article (01/2016)
2.	Belchamber, Kylie B R: 1 article (01/2016)
3.	Bewley, Martin A: 1 article (01/2016)
4.	Brightling, Christopher E: 1 article (01/2016)
5.	Budd, Richard C: 1 article (01/2016)
6.	COPDMAP: 1 article (01/2016)
7.	Chana, Kirandeep K: 1 article (01/2016)
8.	Dockrell, David H: 1 article (01/2016)
9.	Donaldson, Gavin: 1 article (01/2016)
10.	Donnelly, Louise E: 1 article (01/2016)

1.	Chronic Obstructive Pulmonary Disease (COPD) 01/01/2016 - "Conversely PF4950834, but not other inhibitors, enhanced efferocytosis in COPD AM and MDM. "